Vivo Infusion Acquires Neurology Institute of San Antonio and Vista Infusions
Deal News | Jan 09, 2025 | InTandem
Vivo Infusion, a prominent provider of ambulatory infusion services, has announced its acquisition of the Neurology Institute of San Antonio (NISA) and Vista Infusions. The acquisition marks a significant expansion for Vivo Infusion, now managing nearly 90 infusion centers across 15 states. NISA and Vista are noted leaders in the sector and specialize in neurological and autoimmune diseases. This transaction enables Vivo Infusion to strengthen its foothold in Texas, increasing the total number of centers in the state to 20, including facilities in major cities like Dallas, Houston, and San Antonio. The acquisition highlights Vivo's strategy to partner with leading physician practices, such as those of Drs. Suzanne Gazda and Braden Neiman, to enhance patient care quality while maximizing value. Fifth Third Securities acted as the exclusive financial advisor. Financial terms were not disclosed.
Sectors
- Healthcare
- Private Equity
Geography
- United States – The operations and expansion of Vivo Infusion and the acquired entities, NISA and Vista Infusions, are based in the United States, with specific reference to states like Texas.
- Texas – The acquisition specifically enhances Vivo Infusion's presence in Texas with additional centers in cities such as San Antonio, Dallas, and Houston.
Industry
- Healthcare – The article is centred around Vivo Infusion, which provides healthcare services, specifically ambulatory infusion services for neurological and autoimmune diseases.
- Private Equity – InTandem, a private equity firm, is involved as the backer of Vivo Infusion, indicating the role of private equity in funding and expanding healthcare services.
Financials
- Not Disclosed – Financial terms of the transaction between Vivo Infusion and the acquired companies were not disclosed.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Vivo Infusion | Bidding Company | Company | A leading provider of ambulatory infusion and injection services, expanding its footprint with recent acquisitions. |
| Neurology Institute of San Antonio (NISA) and Vista Infusions | Target Company | Company | A recognized provider of ambulatory infusion services and neurological treatments, now acquired by Vivo Infusion. |
| InTandem | Private Equity Firm | Company | The private equity firm backing Vivo Infusion. |
| Fifth Third Securities | Financial Advisor | Company | Served as the exclusive financial advisor to NISA and Vista Infusions for the transaction. |
| Dr. Suzanne Gazda | Key Partner | Person | Neurologist and key partner in the acquisition by Vivo Infusion. |
| Dr. Braden Neiman | Key Partner | Person | Neurologist and key partner in the acquisition by Vivo Infusion. |